Literature DB >> 17564643

Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department.

David Herd1, Brian J Anderson.   

Abstract

BACKGROUND: The aim of this study was to describe ketamine pharmacokinetics in children to simulate time-concentration profiles to predict duration of concentrations associated with anesthesia, arousal and analgesia.
METHODS: Children presenting for painful procedures in the Emergency Dept were given ketamine 1-1.5 mgxkg(-1) i.v. Blood was assayed for ketamine on 3-6 occasions (median 3) over the subsequent 14-152 min (median 28.5). A population pharmacokinetic analysis was undertaken by using nonlinear mixed effects models (NONMEM). Simulation was used to predict time-concentration profiles in this cohort
RESULTS: There were 188 observations from 54 children (age 8.3 sd 3.5 years, weight 32.5 sd 15.6 kg). A two-compartment (central, peripheral) linear disposition model fitted data better than a one-compartment model. Population parameter estimates and their between subject variability (BSV), standardized to a 70-kg person using allometric models, were central volume (V1) 38.7 (BSV 64%) l.70 kg(-1), peripheral volume of distribution (V2) 102 (51.7%) l.70 kg(-1), clearance (CL) 90 (38.1%) l.h(-1) 70 kg(-1) and intercompartment clearance (Q) 215 (19%) l.h(-1) 70 kg(-1). At 10 min half of the children given 1 mgxkg(-1) will have a serum concentration below 0.75 mgxl(-1). This is a concentration associated with 'awakening' in adults. However, almost all the children will still have a serum concentration above 0.1 mgxl(-1), a level associated with analgesia in adults.
CONCLUSIONS: Ketamine 1 mgxkg(-1) i.v. provides satisfactory serum concentrations for children undergoing sedation for painful procedures of <5-min duration and produces concentrations associated with analgesic effect for more than 10 min. Clearance increases with decreasing age in children. The relationship between serum concentration and effect is poorly defined in children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564643     DOI: 10.1111/j.1460-9592.2006.02145.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  9 in total

1.  Pupillary reflex dilation in response to incremental nociceptive stimuli in patients receiving intravenous ketamine.

Authors:  Nada Sabourdin; Thomas Giral; Risa Wolk; Nicolas Louvet; Isabelle Constant
Journal:  J Clin Monit Comput       Date:  2017-10-17       Impact factor: 2.502

2.  Rapid administration technique of ketamine for pediatric forearm fracture reduction: a dose-finding study.

Authors:  Sri S Chinta; Charles R Schrock; John D McAllister; David M Jaffe; Jingxia Liu; Robert M Kennedy
Journal:  Ann Emerg Med       Date:  2015-01-14       Impact factor: 5.721

3.  Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists.

Authors:  Brooke M Roberts; Patricia A Seymour; Christopher J Schmidt; Graham V Williams; Stacy A Castner
Journal:  Psychopharmacology (Berl)       Date:  2010-04-20       Impact factor: 4.530

Review 4.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

Review 5.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

6.  Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.

Authors:  Christoph P Hornik; Daniel Gonzalez; John van den Anker; Andrew M Atz; Ram Yogev; Brenda B Poindexter; Kee Chong Ng; Paula Delmore; Barrie L Harper; Chiara Melloni; Andrew Lewandowski; Casey Gelber; Michael Cohen-Wolkowiez; Jan Hau Lee
Journal:  J Clin Pharmacol       Date:  2018-04-20       Impact factor: 2.860

7.  Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-γ expression of T cells in vitro?: A prospective, randomized, double-blind study.

Authors:  Naibao Zhou; Zhijian Fu; Hao Li; Kaiguo Wang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Procedural moderate sedation with ketamine in pediatric critical care unit.

Authors:  Tarek R Hazwani; Hala Al-Alem
Journal:  Avicenna J Med       Date:  2017 Jan-Mar

9.  The PICHFORK (Pain InCHildren Fentanyl OR Ketamine) trial comparing the efficacy of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries: study protocol for a randomized controlled trial.

Authors:  Andis Graudins; Robert Meek; Diana Egerton-Warburton; Robert Seith; Trentham Furness; Rose Chapman
Journal:  Trials       Date:  2013-07-10       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.